Literature DB >> 24000122

Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.

Yekaterina B Khotskaya1, Benjamin H Beck, Douglas R Hurst, Zhenbo Han, Weiya Xia, Mien-Chie Hung, Danny R Welch.   

Abstract

Metastatic dissemination is a multi-step process that depends on cancer cells' ability to respond to microenvironmental cues by adapting adhesion abilities and undergoing cytoskeletal rearrangement. Breast Cancer Metastasis Suppressor 1 (BRMS1) affects several steps of the metastatic cascade: it decreases survival in circulation, increases susceptibility to anoikis, and reduces capacity to colonize secondary organs. In this report, BRMS1 expression is shown to not significantly alter expression levels of integrin monomers, while time-lapse and confocal microscopy revealed that BRMS1-expressing cells exhibited reduced activation of both β1 integrin and focal adhesion kinase, and decreased localization of these molecules to sites of focal adhesions. Short-term plating of BRMS1-expressing cells onto collagen or fibronectin markedly decreased cytoskeletal reorganization and formation of cellular adhesion projections. Under 3D culture conditions, BRMS1-expressing cells remained rounded and failed to reorganize their cytoskeleton and form invasive colonies. Taken together, BRMS1-expressing breast cancer cells are greatly attenuated in their ability to respond to microenvironment changes.
© 2013 Wiley Periodicals, Inc. © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  BRMS1; CTC; adhesion; integrins; metastasis

Mesh:

Substances:

Year:  2013        PMID: 24000122      PMCID: PMC3939074          DOI: 10.1002/mc.22068

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  80 in total

1.  BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.

Authors:  Alykhan S Nagji; Yuan Liu; Edward B Stelow; George J Stukenborg; David R Jones
Journal:  J Pathol       Date:  2010-06       Impact factor: 7.996

Review 2.  The regulation of leucocyte transendothelial migration by endothelial signalling events.

Authors:  Mar Fernandez-Borja; Jaap D van Buul; Peter L Hordijk
Journal:  Cardiovasc Res       Date:  2010-01-12       Impact factor: 10.787

Review 3.  Structural basis of integrin transmembrane activation.

Authors:  Wei Wang; Bing-Hao Luo
Journal:  J Cell Biochem       Date:  2010-02-15       Impact factor: 4.429

Review 4.  Hypoxia, inflammation, and the tumor microenvironment in metastatic disease.

Authors:  Elizabeth C Finger; Amato J Giaccia
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

Review 5.  The final steps of integrin activation: the end game.

Authors:  Sanford J Shattil; Chungho Kim; Mark H Ginsberg
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04       Impact factor: 94.444

Review 6.  Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.

Authors:  Dalit Barkan; Jeffrey E Green; Ann F Chambers
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

Review 7.  Rolling back neutrophil adhesion.

Authors:  Rodger P McEver
Journal:  Nat Immunol       Date:  2010-04       Impact factor: 25.606

Review 8.  Linking actin dynamics and gene transcription to drive cellular motile functions.

Authors:  Eric N Olson; Alfred Nordheim
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05       Impact factor: 94.444

Review 9.  Targeting focal adhesion kinase signaling in tumor growth and metastasis.

Authors:  Joerg Schwock; Neesha Dhani; David W Hedley
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

10.  In vivo nano-imaging of membrane dynamics in metastatic tumor cells using quantum dots.

Authors:  Kohsuke Gonda; Tomonobu M Watanabe; Noriaki Ohuchi; Hideo Higuchi
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

View more
  9 in total

1.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

2.  In vitro biophysical, microspectroscopic and cytotoxic evaluation of metastatic and non-metastatic cancer cells in responses to anti-cancer drug.

Authors:  Qifei Li; Lifu Xiao; Sitaram Harihar; Danny R Welch; Elizabeth Vargis; Anhong Zhou
Journal:  Anal Methods       Date:  2015-11-03       Impact factor: 2.896

3.  S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer.

Authors:  Yekaterina B Khotskaya; Aarthi Goverdhan; Jia Shen; Mariano Ponz-Sarvise; Shih-Shin Chang; Ming-Chuan Hsu; Yongkun Wei; Weiya Xia; Dihua Yu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

Review 4.  BRMS1: a multifunctional signaling molecule in metastasis.

Authors:  Rosalyn C Zimmermann; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

5.  Expression of the metastasis suppressor BRMS1 in uveal melanoma.

Authors:  Bruna V Ventura; Carlos Quezada; Shawn C Maloney; Bruno F Fernandes; Emilia Antecka; Claudia Martins; Silvin Bakalian; Sebastian di Cesare; Miguel N Burnier
Journal:  Ecancermedicalscience       Date:  2014-03-11

6.  Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.

Authors:  Emily H Hall; Yuan Liu; Aizhen Xiao; Lisa Shock; David L Brautigan; Marty W Mayo; Prasad S Adusumilli; David R Jones
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

7.  Impact of PKCε downregulation on autophagy in glioblastoma cells.

Authors:  Ewa Toton; Aleksandra Romaniuk; Natalia Konieczna; Johann Hofmann; Jan Barciszewski; Maria Rybczynska
Journal:  BMC Cancer       Date:  2018-02-13       Impact factor: 4.430

8.  Perturbation of BRMS1 interactome reveals pathways that impact metastasis.

Authors:  Rosalyn C Zimmermann; Mihaela E Sardiu; Christa A Manton; Md Sayem Miah; Charles A S Banks; Mark K Adams; Devin C Koestler; Douglas R Hurst; Mick D Edmonds; Michael P Washburn; Danny R Welch
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.752

9.  ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.

Authors:  Hongtao Ma; Lauren S Gollahon
Journal:  Int J Mol Sci       Date:  2016-01-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.